Back to top
more

Becton, Dickinson and Company (BDX)

(Delayed Data from NYSE)

$233.25 USD

233.25
1,948,944

-3.09 (-1.31%)

Updated Sep 5, 2024 04:00 PM ET

After-Market: $233.15 -0.10 (-0.04%) 7:50 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (170 out of 251)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Based in Franklin Lakes, NJ, Becton, Dickinson and Company (BDX) commonly known as BD, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. In fiscal 2019, BD’s revenues increased 8.2% to $17.29 billion. Earlier, BD’s operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. However, the company’s organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional.

Here's Why You Should Retain BD (BDX) Stock in Your Portfolio

Investors continue to be optimistic about BD (BDX) owing to its slew of regulatory approvals and strategic deals.

BD's (BDX) Buyout of Venclose to Improve Patient Outcome

BD's (BDX) acquisition of Venclose is expected to deliver a patient-centric approach to care.

The Zacks Analyst Blog Highlights: Accenture, Raytheon, Becton, Dickinson and Co, Boeing and Gilead Sciences

The Zacks Analyst Blog Highlights: Accenture, Raytheon, Becton, Dickinson and Co, Boeing and Gilead Sciences

Mark Vickery headshot

Top Analyst Reports for Accenture, Raytheon & Becton, Dickinson

Today's Research Daily features new research reports on 16 major stocks, including Accenture plc (ACN), Raytheon Technologies Corporation (RTX), and Becton, Dickinson, and Company (BDX).

BD (BDX) Beats on Q4 Earnings and Revenues, FY22 View Issued

Each of BD's (BDX) core units witnesses strong revenue growth in the fiscal fourth quarter, driving up the overall top line.

Becton Dickinson (BDX) Q4 Earnings and Revenues Beat Estimates

Becton Dickinson (BDX) delivered earnings and revenue surprises of 6.58% and 4.73%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Trina Mukherjee headshot

Medical Products' Nov 4 Earnings Roster: BDX, ZBH & More

The Medical Product companies' Q3 results are likely to reflect huge adoption of their COVID-related support products. Let's see how BDX, ZBH, ABC and XRAY are poised ahead of their earnings releases.

Is a Surprise Coming for BD (BDX) This Earnings Season?

BD (BDX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Clover Health (CLOV) to Report Q3 Earnings: What's in Store?

Clover Health's (CLOV) third-quarter results are likely to benefit from Direct Contracting and strategic partnerships.

Zimmer Biomet (ZBH) to Report Q3 Earnings: What's in Store?

Strong surgeon registrations of the Signature One surgical planning system for shoulder procedures are likely to have driven Zimmer Biomet's (ZBH) growth in Q3.

Becton Dickinson (BDX) Expected to Beat Earnings Estimates: Should You Buy?

Becton Dickinson (BDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BD (BDX) Gears Up for Q4 Earnings: What's in the Offing?

Continued strength in BD's (BDX) Life Sciences and Interventional segments is expected to have driven up Q4 sales.

IDEXX (IDXX) to Report Q3 Earnings: What's in the Cards?

Strong organic recurring revenue growth in CAG diagnostics business and the recent ezyVet buyout are likely to have contributed to growth for IDEXX (IDXX).

What's in Store for Henry Schein (HSIC) in Q3 Earnings?

Strengthening demand in the global dental and medical markets along with the recent investments are likely to have contributed to Henry Schein's (HSIC) Q3 performance.

Can Becton Dickinson (BDX) Keep the Earnings Surprise Streak Alive?

Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

SmileDirectClub (SDC) Introduces Two New Water Flossers

SmileDirectClub (SDC) launched the new Large Tank and Compact Water Flossers, currently available at Shop.SmileDirectClub.com, Amazon, Walmart and Walmart.com.

Zacks.com featured highlights include: Becton, Dickinson and Co, Ternium and AutoNation

Zacks.com featured highlights include: Becton, Dickinson and Co, Ternium and AutoNation

QIAGEN's (QGEN) New Manchester Facility to Fortify UK Foothold

QIAGEN's (QGEN) new campus is expected to bring the benefits of transformational molecular diagnostics to Manchester and the global healthcare market.

Tirthankar Chakraborty headshot

3 Must-Buy Efficient Stocks to Boost Portfolio Returns

Becton, Dickinson and Company (BDX), Ternium (TX) & AutoNation (AN) are three must-buy efficient stocks that can enrich your portfolio now.

BDX or MMSI: Which Is the Better Value Stock Right Now?

BDX vs. MMSI: Which Stock Is the Better Value Option?

Teladoc (TDOC) to Report Q3 Earnings: What's in the Cards?

Robust customer uptake and novel innovations are likely to have contributed to growth for Teladoc (TDOC).

Intuitive Surgical (ISRG) Q3 Earnings Match Estimates, Up Y/Y

Intuitive Surgical's (ISRG) third-quarter results reflect strong segmental performance.

The Zacks Analyst Blog Highlights: Oracle, Lowe's, Starbucks, Goldman Sachs and Becton, Dickinson and Co

The Zacks Analyst Blog Highlights: Oracle, Lowe's, Starbucks, Goldman Sachs and Becton, Dickinson and Co

Sheraz Mian headshot

Top Stock Reports for Oracle, Lowe's & Starbucks

Today's Research Daily features new research reports on 16 major stocks, including Oracle Corporation (ORCL), Lowe's Companies, Inc. (LOW), and Starbucks Corporation (SBUX).

Here's Why You Should Invest In Henry Schein (HSIC) Now

Investors continue to be optimistic about Henry Schein (HSIC) on its extensive global foothold and raised 2021 earnings guidance.